David M. Spencer, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 10,000 shares at $7.04 ($70K) on 2018-09-04, disclosed to the SEC on 2018-09-05.
Open-market sale of $70k BLCM by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-09-23 | $453K | — | Filing → |